Home / Nervous system / Buprenorphine, Combinations
ATC N07BC51 · Drugs Used in Opioid Dependence
Buprenorphine, Combinations shortage
As of 2 Nov 2026, Buprenorphine, Combinations has a reported shortage in 4 of the 15 countries we track (Canada, Czechia, Norway, Sweden), covering 12 products from 3 companies.
Countries4/15
Products12packs or presentations
Companies30 listed
Short since16 Dec 202423 months ago
Earliest return31 Dec 2026company estimate
Main reasonNot stated
United StatesNo reported shortageCanada4 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia1 product shortNorway5 products shortSweden2 products shortJapanNo reported shortageAustraliaNo reported shortage
Timeline
CanadaCzechiaNorwaySweden
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group N07BC · Drugs Used in Opioid DependenceAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | SUBOXONE (28) discontinuation | INDIVIOR UK LIMITED | not given | 28 Feb 2027 | Not stated |
| CA | SUBOXONE (28) discontinuation | INDIVIOR UK LIMITED | not given | 16 Feb 2027 | Not stated |
| CA | SUBOXONE (28) discontinuation | INDIVIOR UK LIMITED | not given | 11 Feb 2027 | Not stated |
| CA | SUBOXONE (28) discontinuation | INDIVIOR UK LIMITED | not given | 31 Dec 2026 | Not stated |
| CZ | LIBROXAR 2MG/0,5MG 2MG/0,5MG SLG TBL NOB 28 | Heaton k.s., Praha | 16 Dec 2024 | 31 Dec 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| NO | Suboxone 12 mg/3 mg sublingvalfilm, 28x1 stk dosepose | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Suboxone 16 mg/4 mg sublingvaltablett, 28 stk blisterpakning | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Suboxone 2 mg/0,5 mg sublingvalfilm, 28x1 stk dosepose | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Suboxone 2 mg/0,5 mg sublingvaltablett, 28 stk blisterpakning | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Suboxone 8 mg/2 mg sublingvalfilm, 28x1 stk dosepose | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| SE | Suboxone 16 mg/4 mg Blister, 28 tabletter (PD: Orifarm AB) | 15 Dec 2025 | not given | Not stated | |
| SE | Buprenorphine/Naloxone Viatris 8 mg/2 mg Blister, 28 x 1 tabletter (endos) anticipated | 4 Jan 2027 | 4 Apr 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.